Introduction {#sec1-1}
============

Mother-to-child transmission prevention programs have dramatically reduced the mother-to-child transmission rate increasing the HIV exposed uninfected infant (HEU) population. Many research groups have focused on this population and demonstrated a high mortality and morbidity in the HEU population when compared to HIV negative unexposed (HU) infants from HIV uninfected mothers.^[@ref1]^ This increased morbidity/mortality in HEU infants has been linked to recurrent infections.^[@ref1],[@ref4]^

Research on HIV exposed infants has reported a number of immune cell characteristics of this population including lower numbers of naive CD4^+^ cells, reduced thymic output ^[@ref9]^ and an impaired humoral response to vaccines.^[@ref10]^ Furthermore, a number of hematological alterations such as low levels hemoglobin Granulocytes, lymphocytes and thrombocytes have also been reported in HEU infant.^[@ref11],[@ref12]^ Most studies investigating hematological parameters of HEU were carried in France, Netherland, Spain and the USA.^[@ref11]^ These studies revealed low hemoglobin concentrations, reduced neutrophil and platelet counts as well as signs of moderate-to-severe toxicity in HIV-l/ART-exposed children. Data on how HIV or HIV therapy affects African HEU infants is limited.

The present cross-sectional study investigated blood figurative elements levels in HEU infants from Gabon in Central Africa.

Materials and Methods {#sec1-2}
=====================

In the setting of The National Laboratory of Public Health in Libreville (Gabon), from January to December 2015, a total of fifteen (15) healthy HEU and nine (9) HU infants aged 6 to 12 weeks were recruited for the present study. For all infants, we collected information on age, childbirth (vaginal delivery or caesarean section and preterm or full-term birth), infant preventive therapy and breastfeeding. To establish HIV perinatal infection, peripheral blood was taken at 4, 6 and 24 weeks after delivery and tested for HIVRNA (RT-PCR Biomerieux, France). At 18 months, an additional sample was taken to detect anti-HIV-1 antibodies by ELISA. The National Laboratory of Public Health Ethics Review Board approved this study protocol. Consent forms were obtained from parents before enrolment.

Blood count and hemogram {#sec2-1}
------------------------

Blood was collected from infants in a 5 mL EDTA tubes. Homogenized samples were analyzed using the Mindray BC-3000 plus instrument (Mindray, Shenzhen, China).

The measured blood components were: white blood cells count, differential leukocytes count, red blood cells count and morphology (mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC)), platelet count and sizing (mean platelet volume (MPV) included), hemoglobin rate, hematocrit and the red cell distribution width (RDW).

Statistical analysis {#sec2-2}
--------------------

All statistical were done using the software GraphPad Prism version 6. Parameters levels in HU and HEU infants were comparatively analyzed using the Mann-Whitney test. Descriptive statistics (frequencies or percentages) were used to characterize the study population.

Results {#sec1-3}
=======

Infants' information {#sec2-3}
--------------------

We found that 14 of the 15 HEU infants, were born vaginally and one by C-section. Only two of the HEU-infants were breastfeed, and only one was not on preventive therapy ([Table 1](#table001){ref-type="table"}).

Blood count and hemogram {#sec2-4}
------------------------

The leukocytes evaluation showed no significant difference in the total white blood cells, red blood cells, lymphocytes, monocytes and granulocytes counts between HEU and HU infants ([Table 1](#table001){ref-type="table"}). No significant different were observed on, hemoglobin concentration, hematocrit, MCV, MCH, MCHC and RDW ([Table 2](#table002){ref-type="table"}).

Platelet count was significantly higher in HEU-infants than HU-infants (P=0.01). The difference between the groups was physiologically significant ([Table 2](#table002){ref-type="table"} and [Figure 1](#fig001){ref-type="fig"}).

The mean platelet volume (MPV) was significantly lower in HEU-infants than HU-infants (P\<0.05) ([Table 2](#table002){ref-type="table"} and [Figure 2](#fig002){ref-type="fig"}), however, HU and HEU infants MVPs were within normal range (6-11.1 fl).

Number of infants with events of clinically relevant hematological abnormalities {#sec2-5}
--------------------------------------------------------------------------------

*Hemoglobin concentration:* 5 (33%) of the 15 HEU infants had their hemoglobin concentration below the normal age associated ranges, whereas 2 of the 9 (22%) HU had their hemoglobin concentration below the normal ranges (10.4-16.5 g/dL).

*Thrombocytes numeration:* 12 out 15 (80%) HEU infants had their thrombocytes count above the normal age associated ranges, whereas only 2 out of 8 (25%) HU had their thrombocytes count above the normal age associated ranges (150,000-400,000 cells/mm^3^).

*Leucocytes and lymphocytes numeration:* 2 (13%) and 5 (33%) HEU infants had respectively their leucocytes and lymphocytes count below the normal age associated ranges (leucocytes \[4000-11,000 cells/mm^3^\], lymphocytes \[7000-17,000 cells/mm^3^\]). All HU infants except from 1 had their lymphocytes count within the normal range.

![Platelets count in HIV-exposed uninfected (HEU) and HIV unexposed (HU) infants. The platelets count was significantly higher in HEU infants than HU infants (P=0.01). The observed difference was physiologically and clinically relevant.](hr-11-3-7056-g001){#fig001}

###### 

HIV-exposed and unexposed infants information (age, gender delivery mode, preventive therapy, etc.)

  Infants code   Age, weeks   Gender   Delivery route   Delivery time   Infants\' preventive therapy   Breastfed
  -------------- ------------ -------- ---------------- --------------- ------------------------------ --------------
  HEU3           12           Female   Vaginally        Not informed    Zidovidine/Bactrim             No
  HEU4           6            Female   Vaginally        Full-term       No information                 Missing data
  HEU5           8            Female   Vaginally        Full-term       Zidovidine/Bactrim             No
  HEU6           6            Male     Vaginally        Not informed    NVP/Bactrim                    No
  HEU8           10           Male     Vaginally        Not informed    NVP/Bactrim                    No
  HEU9           10           Male     Vaginally        Full-term       NVP/Bactrim                    No
  HEU10          6            Male     Vaginally        Full-term       NVP/Bactrim                    No
  HEU11          6            Female   C-section        Missing data    NVP/Bactrim                    No
  HEU13          6            Female   Vaginally        Full-term       NVP/Bactrim                    No
  HEU14          12           Male     Vaginally        Not informed    NVP/Bactrim+NVP                Yes
  HEU15          6            Male     Vaginally        Full-term       NO                             Yes
  HEU16          6            Male     Vaginally        Full-term       NVP/Bactrim                    No
  HEU17          8            Male     Vaginally        Not informed    NVP/Bactrim                    No
  HEU18          7            Male     Vaginally        Full-term       NVP/Bactrim                    No
  HEU19          6            Female   Vaginally        Full-term       NVP/Bactrim                    No
  HU1            6            Male     Vaginally        Missing data    NA                             Yes
  HU2            8            Male     Vaginally        Missing data    NA                             Yes
  HU3            12           Male     Vaginally        Missing data    NA                             Yes
  HU4            12           Female   Vaginally        Missing data    NA                             Yes
  HU5            12           Female   Vaginally        Missing data    NA                             Yes
  HU6            8            Female   Vaginally        Missing data    NA                             Yes
  HU7            8            Female   Vaginally        Missing data    NA                             Yes
  HU8            8            Female   Vaginally        Missing data    NA                             Yes
  HU9            6            Male     Vaginally        Missing data    NA                             Yes

*Granulocytes numeration:* 2 (13%) out of 15 HEU infants had their Granulocytes count below the normal age associated ranges \[2000-7000 cells/mm^3^\]. All HU infants except from 1 had had their Granulocytes count within the normal range.

Discussion {#sec1-4}
==========

Clinically relevant hematological abnormalities events were found to be higher in HEU infants when compared with HU infants. The rate of infants with low lymphocytes count was higher by 21% in HEU infants as compared to HU-infants. The prevalence of anemia was also higher in HEU infants (33%) compared to HU infants (22%). Similar observations have been described in the literature.^[@ref12],[@ref15]^ Our study showed that HEU infants had significantly higher platelets count than HU-infants. Moreover, the difference between the groups was physiologically or clinically relevant. Indeed, with a prevalence of 80% of HEU infants against 25% in HU infants (cut-off set at 400,000 cells/mm^3^), *mild* thrombocytosis seems to be a feature of HEU infants. In newborns, thrombocytosis can be caused by a large number of conditions: inflammation, infection, drug therapy preterm or C-section birth etc. Here, in utero exposure to a pro-inflammatory fetal environment could explain the high prevalence thrombocytosis observed in HEUinfants. ^[@ref16],[@ref17]^

![HIV-exposed uninfected (HEU) and HIV unexposed (HU) infants\' mean platelet volume: the mean platelet volume (MPV) was significantly lower in HEU infants than HU infants (P=0.04). The observation has no physiological significance as HEU MVPs is within normal range (6-11.1 fl).](hr-11-3-7056-g002){#fig002}

###### 

Median, mean and ranges of hematological parameters measured in HIV-exposed and unexposed infants.

                                     Median   Mean     Min    Max      25% percentile   75% percentile   P-value
  ---------------------------------- -------- -------- ------ -------- ---------------- ---------------- ---------
  Granulocytes (cells/mm^3^)                                                                             0.5
      HEU-infants (n=13)             2700     3231     1600   6900     2350             4100             
      HU-infants (n=9)               4000     3811     1700   6400     2150             5200             
  Lymphocytes (cells/mm3)                                                                                0.34
      HEU-infants (n=14)             4900     5143     2600   10,000   3775             5775             
      HU-infants (n=9)               5400     5633     3500   7600     4650             6950             
  Leucocytes (cells/mm3)                                                                                 0.38
      HEU-infants (n=14)             9300     9979     6100   18,800   7950             11,350           
      HU-infants (n=9)               11,200   10,889   5900   15,100   8300             13,900           
  Red blood cells                                                                                        0.27
      HEU-infants (n=15)             3.37     3.482    2.86   4.31     3.17             3.66              
      HU-infants (n=9)               3.63     4.159    3.12   8.36     3.255            4.245             
  Platelets (x103/mm3)                                                                                   \<0.013
      HEU-infants (n=15)             464      462.9    302    633      408              497              
      HU-infants (n=8)               361      353.9    138    489      323              424.5            
  Hemoglobin                                                                                             0.25
      HEU-infants (n=15)             10.5     10.45    8.4    12.5     9.5              11.5             
      HU-infants (n=9)               11.3     11.31    9.1    14.2     9.95             12.45            
  Hematocrit                                                                                             0.42
      HEU-infants (n=15)             34.1     32.78    25.4   38.6     29.3             35.8             
      HU-infants (n=9)               34       38.91    29.6   77.5     31.25            38.55            
  Mean platelets volume                                                                                  \<0.043
      HEU-infants (n=15)             7.9      8.073    6.7    9.6      7.6              8.7              
      HU-infants (n=9)               8.9      8.9      7.6    10.3     8.15             9.75             
  Mean corpuscular hemoglobin conc                                     0.96                              
      HEU-infants (n=15)             31.8     31.88    29.1   33.7     31.4             32.8             
      HU-infants (n=9)               32       30.56    18.3   34.7     29.7             33.15            
  Mean corpuscular volume                                                                                0.99
      HEU-infants (n=15)             94.3     94.52    80.9   114.7    85.6             102.7            
      HU-infants (n=9)               94.9     94.09    84.4   98       92.75            97.75            
  Mean corpuscular hemoglobin                                                                            0.91
      HEU-infants (n=15)             29.5     30.07    26.3   35       27.2             32.8             
      HU-infants (n=9)               30.3     28.69    16.9   33       27.4             31.1             
  Red cell distribution width                                                                            0.65
      HEU-infants (n=15)             16       15.98    15.5   16.6     15.8             16.2             
      HU-infants (n=9)               15.9     16.12    15.7   16.8     15.75            16.6             

MVP levels were within normal range from both infant populations although HEU-infants had significantly lower MPV than HU-infants. HEU-infant's high platelet count and low MVP suggest a reactive thrombocytosis frequently observed during inflammation or infection.^[@ref18],[@ref19]^

Others groups including Bunders and associates have also reported an average platelets count above the normal age associated range^[@ref13]^ in HEU infants. This is consistent with our findings. However, in the Bunders and colleague study, no statistically significant difference in platelets count was found between controls and HEU infants. Pacheco *et al.*,^[@ref12]^ reported that HEU infants exposed to ARV therapy have small but significant differences in hemoglobin concentrations, lymphocytes neutrophil, and platelets counts than HEU infants not exposed to ARV therapy. Although their study did not include comparison with HU infants, their data showed that all HEU infants aged 8-16 weeks had their platelets counts above the normal range of 400000 cells/mm^3^. Again, this is similar to what we found. Considering HEU infants in the same age range (6-16 weeks), in our setting, the average hemoglobin level and average lymphocytes count was lower than what Pacheco and colleague observed.

HUE-infants have increased mortality/ morbidity due to infections. Today it is increasingly clear that aspects of their immune response are impaired,^[@ref20]^ which might explain their susceptibility. Based on our data and previously reported data on HEU-infants, this group of infants has altered blood elements, whether those alterations are central (bone marrow) or only peripheral (peripheral blood) need to investigated further. Also, consequences of these alterations also need to be investigated.

Our study design has its limitation, as infants were not followed up to determine the transient or long-lasting character of our observations. Another limit resides in the fact that, in the present study, it is impossible to separate the effect of HIV-exposure from the effect of antiretroviral therapy (ART) exposure.

Conclusions {#sec1-5}
===========

Our results show HEU have significantly higher platelets count than HU infants. Further studies are needed to separate the effect of HIV-exposure from the effect of antiretroviral therapy (ART) exposure on infant biology.
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